Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (81-90 of 301) with videos related to

Pageof 31
Sort By:
Advances in Experimental Medicine and Biology|January 5, 2002
T cell response to tumor antigens and its therapeutic use in cancer patientsG Parmiani, C Castelli, P Dalerba, et al.
Melanoma Research|August 1, 1991
An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysisA Mazzocchi, M Rodolfo, G Parmiani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acidG Pratesi, M Rodolfo, G Rovetta, et al.
European Journal of Immunology|October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cellsZ Wang, F Arienti, G Parmiani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumoursM Rodolfo, C Bassi, C Salvi, et al.
International Journal of Cancer|April 1, 1994
Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profilesC Maccalli, R Mortarini, G Parmiani, et al.
Immunology Letters|September 21, 2000
Cytokines in cancer therapyG Parmiani, L Rivoltini, G Andreola, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2000
Tumour immunotherapy: the adjuvant treatment of the 21st century?A J Bremers, P J Kuppen, G Parmiani
Tumori|November 1, 1970
[Study of the transplacental toxicity and carcinogenesis in rats treated with hexamethylenetetramine]G Della Porta, J R Cabral, G Parmiani
International Journal of Cancer|October 15, 1986
Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gammaA Anichini, R Mortarini, G Fossati, et al.
Pageof 31

Showing results (81-90 of 301) with videos related to

Sort By:
Pageof 31
Advances in Experimental Medicine and Biology|January 5, 2002
T cell response to tumor antigens and its therapeutic use in cancer patientsG Parmiani, C Castelli, P Dalerba, et al.
Melanoma Research|August 1, 1991
An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysisA Mazzocchi, M Rodolfo, G Parmiani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acidG Pratesi, M Rodolfo, G Rovetta, et al.
European Journal of Immunology|October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cellsZ Wang, F Arienti, G Parmiani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumoursM Rodolfo, C Bassi, C Salvi, et al.
International Journal of Cancer|April 1, 1994
Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profilesC Maccalli, R Mortarini, G Parmiani, et al.
Immunology Letters|September 21, 2000
Cytokines in cancer therapyG Parmiani, L Rivoltini, G Andreola, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2000
Tumour immunotherapy: the adjuvant treatment of the 21st century?A J Bremers, P J Kuppen, G Parmiani
Tumori|November 1, 1970
[Study of the transplacental toxicity and carcinogenesis in rats treated with hexamethylenetetramine]G Della Porta, J R Cabral, G Parmiani
International Journal of Cancer|October 15, 1986
Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gammaA Anichini, R Mortarini, G Fossati, et al.
Pageof 31